Novel KMT2B mutation causes cerebellar ataxia: Expanding the clinical phenotype

Clin Genet. 2021 Dec;100(6):743-747. doi: 10.1111/cge.14055. Epub 2021 Sep 8.

Abstract

Hereditary cerebellar ataxias comprise a heterogeneous group of neurodegenerative disorders affecting the cerebellum and/or cerebellar pathways. Next-generation sequencing techniques have contributed substantially to the expansion of ataxia-causing genes, including genes classically described in alternative phenotypes. Herein, we describe a patient with adult-onset cerebellar ataxia, minor dystonia, neuropathy, seizure and ophthalmological pathology, who bears a novel variant in KMT2B (NM_014727.2:c.3334 + 1G > A). Bioinformatic analysis suggested this variant completely abolished the splice-site at exon 8/intron 8, which was confirmed through analysis of mRNA extracted from fibroblasts. Exon 8 skipping would ultimately translate as an in-frame deletion at the protein level, corresponding to the loss of 91 aminoacids [p.(Gly1020_Asn1111del)]. So far, KMT2B disease causing variants have been described in patients with dystonia or neurodevelopmental delay, with no reports of a cerebellar predominant phenotype. Our findings highlight the possible role of KMT2B as a gene involved in hereditary cerebellar ataxias.

Keywords: KMT2B; cerebellar ataxia; dystonia; genetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Brain / abnormalities
  • Brain / diagnostic imaging
  • Cerebellar Ataxia / diagnosis*
  • Cerebellar Ataxia / genetics*
  • Child
  • Electroencephalography
  • Exome Sequencing
  • Female
  • Gene Expression Profiling
  • Genetic Association Studies* / methods
  • Genetic Predisposition to Disease*
  • Genotype
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Magnetic Resonance Imaging
  • Mutation*
  • Phenotype*

Substances

  • Histone-Lysine N-Methyltransferase
  • KMT2B protein, human